Rights and permissions
About this article
Cite this article
NICE to take over assessment of high cost drugs for rare diseases. Pharmacoecon. Outcomes News 659, 3 (2012). https://doi.org/10.2165/00151234-201206590-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206590-00006